The Administrative Core (Core A) will be responsible for the day-to-day operation of the MT COBRE program. The overall goal of the Phase 111 application of the Molecular Targets COBRE (MT COBRE) is to ensure that the novel targets and compounds which have been identified by MT COBRE faculty are translated to pivotal human clinical trials. Under Dr. Miller's direction, Core A will provide budgetary management, core oversight, manage the Pilot Grant Program and monitor progress of the MT COBRE faculty. The MT COBRE Administrative Assistant and the Program Coordinator will report to the MT COBRE PI and co-Director through this core. The Administrative Core will be responsible for organizing all committee meetings including those of the Steering Committee, the Internal Advisory Committee and the External Advisory Committee. It will provide regular evaluations of research core function and fiscal status. Core A also will provide the requisite reports to the NIH Program administration on an annual basis. During the first ten years of MT COBRE funding. Core A has provided very important support to all of the MT COBRE faculty and has played an important role in the overall success of the program. This core will assume an even more important role during Phase III of the COBRE.
Cancer metabolism and cancer drug development are currently very important areas of research. The MT COBRE program has trained leaders in this area;the funding of Phase III will ensure the continued success and growth of the JGBCC core facilities, and thus it's faculty, and this program.
|Zhao, Guoping; Neely, Aaron M; Schwarzer, Christian et al. (2016) N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins. Oncotarget 7:5924-42|
|Smith, Colin A; Ban, David; Pratihar, Supriya et al. (2016) Allosteric switch regulates protein-protein binding through collective motion. Proc Natl Acad Sci U S A 113:3269-74|
|Garbett, Nichola C; Brock, Guy N (2016) Differential scanning calorimetry as a complementary diagnostic tool for the evaluation of biological samples. Biochim Biophys Acta 1860:981-9|
|Waigel, Sabine; Rendon, Beatriz E; Lamont, Gwyneth et al. (2016) MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes. Genom Data 7:240-2|
|Yaddanapudi, Kavitha; Rendon, Beatriz E; Lamont, Gwyneth et al. (2016) MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation. Cancer Immunol Res 4:101-12|
|Sabo, T Michael; Trent, John O; Lee, Donghan (2015) Population shuffling between ground and high energy excited states. Protein Sci 24:1714-9|
|England, Christopher G; Miller, M Clarke; Kuttan, Ashani et al. (2015) Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm 92:120-9|
|Miller, M Clarke; Ohrenberg, Carl J; Kuttan, Ashani et al. (2015) Separation of Quadruplex Polymorphism in DNA Sequences by Reversed-Phase Chromatography. Curr Protoc Nucleic Acid Chem 61:17.7.1-18|
|Satpathy, Shuchismita R; Jala, Venkatakrishna R; Bodduluri, Sobha R et al. (2015) Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth. Nat Commun 6:7064|
|Andreeva, Kalina; Soliman, Maha M; Cooper, Nigel G F (2015) Regulatory networks in retinal ischemia-reperfusion injury. BMC Genet 16:43|
Showing the most recent 10 out of 46 publications